927
Views
8
CrossRef citations to date
0
Altmetric
Review Articles

Diversity of the bacteriocins, their classification and potential applications in combat of antibiotic resistant and clinically relevant pathogens

, & ORCID Icon
Pages 578-597 | Received 27 Feb 2022, Accepted 13 Jun 2022, Published online: 22 Jun 2022

References

  • Abler LA, Klapes NA, Sheldon BW, Klaenhammer TR. 1995. Inactivation of food-borne pathogens with magainin peptides. J Food Protect. 58(4):381–388.
  • Acedo JZ, van Belkum MJ, Lohans CT, McKay RT, Miskolzie M, Vederas JC. 2015. Solution structure of acidocin B, a circular bacteriocins produced by Lactobacillus acidophilus M46. Appl Environ Microbiol. 81(8):2910–2918.
  • Albano H, Todorov SD, Reenen CA, Hogg T, Dicks LM, Teixeira P. 2007. Characterization of two bacteriocins produced by Pediococcus acidilactici isolated from "Alheira", a fermented sausage traditionally produced in Portugal. Int J Food Microbiol. 116(2):239–247.
  • Alvarez-Sieiro P, Lopez MM, Mu D, Kuipers OP. 2016. Bacteriocins of lactic acid bacteria: extending the family. Appl Microbiol Biotechnol. 100(7):2939–2951.
  • Andreza FSD, Hilana CV, Emile SB, Thaïs Cristina BSSP, Ingolf FN, Maria CFB. 2018. Hyicin 4244, the first sactibiotic described in staphylococci, exhibits an anti-staphylococcal biofilm activity. Int J Antimicrob Agents. 51(3):349–356.
  • Annamalai T, Venkitanarayanan KS, Hoagland TA, Khan MI. 2001. Inactivation of Escherichia coli O157: H7 and Listeria monocytogenes by PR-26, a synthetic antibacterial peptide. J Food Protect. 64(12):1929–1934.
  • Araújo C, Muñoz-Atienza E, Poeta P, Igrejas G, Hernández PE, Herranz C, Cintas LM. 2016. Characterization of Pediococcus acidilactici strains isolated from rainbow trout (Oncorhynchus mykiss) feed and larvae: safety, DNA fingerprinting, and bacteriocinogenicity. Dis Aquat Organ. 119(2):129–143.
  • Arevalo-Villena M, Bartowsky EJ, Capone D, Sefton MA. 2010. Production of indole by wine-associated microorganisms under oenological conditions. Food Microbiol. 27(5):685–690.
  • Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, et al. 2013. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep. 30(1):108–160.
  • Asensio C, Pérez-Diaz JC, Martinez MC, Baquero F. 1976. A new family of low molecular weight antibiotics from enterobacteria. Biochem Biophys Res Commun. 69(1):7–14.
  • Atkins JT, Tillman J, Tan TQ, Demmler GJ. 1994. Pediococcus pentosaceus catheter-associated infection in an infant with gastroschisis. Ped Infect Dis J. 13:75–76.
  • Bae TW, Lee JH, Lee HS, Cho YG. 2016. A case of septic shock following catheter-related infection caused by Lactococcus lactis subsp. lactis in an adult. Lab Med Online. 6(3):187–190.
  • Baindara P, Gautam A, Raghava GPS, Korpole S. 2017a. Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10. Sci Rep. 7(7):46541.
  • Bakhtiary A, Cochrane SA, Mercier P, McKay RT, Miskolzie M, Sit CS, Vederas JC. 2017. Insights into the mechanism of action of the two-peptide lantibiotic lacticin 3147. J Am Chem Soc. 139(49):17803–17810.
  • Ball SC, Sepkowitz K. 1994. Infection due to Bacillus cereus in an injection drug user with AIDS: bacteremia without morbidity. Clin Infect Dis. 19(1):216–217.
  • Banwo K, Sanni A, Tan H. 2013. Functional properties of Pediococcus species isolated from traditional fermented cereal gruel and milk in Nigeria. Food Biotechnol. 27(1):14–38.
  • Barton LL, Rider ED, Coen RW. 2001. Bacteremic infection with Pediococcus: vancomycin-resistant opportunist. Pediatrics. 107(4):775–776.
  • Ben-Gurion R, Hertman I. 1958. Bacteriocin-like material produced by Pasteurella pestis. J Gen Microbiol. 19(2):289–297.
  • Bennett JW, Chung K-T. 2001. Alexander Fleming and the discovery of penicillin. Adv Appl Microbiol. 49:163–184.
  • Bhugaloo-Vial P, Dousset X, Métivier A, Sorokine O, Anglade P, Boyaval P, Marion D. 1996. Purification and amino acid sequences of piscicocins V1a and V1b, two class IIa bacteriocins secreted by Carnobacterium piscicola V1 that display significantly different levels of specific inhibitory activity. Appl Environ Microbiol. 62(12):4410–4416.
  • Bhunia AK. 2018. Bacillus cereus and Bacillus anthracis. In: Foodborne microbial pathogens. p. 193–207. Berlin, Germany: Springer.
  • Brötz H, Bierbaum G, Reynolds PE, Sahl HG. 1997. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur J Biochem. 246(1):193–199.
  • Cao Z, Pan H, Tong H, Gu D, Li S, Xu Y, Ge C, Lin Q. 2016. In vitro evaluation of probiotic potential of Pediococcus pentosaceus L1 isolated from paocai – a Chinese fermented vegetable. Ann Microbiol. 66(3):963–971.
  • Carlson CJ, Kracalik IT, Ross N, Alexander KA, Hugh-Jones ME, Fegan M, Elkin BT, Epp T, Shury TK, Zhang W, et al. 2019. The global distribution of Bacillus anthracis and associated anthrax risk to humans, livestock and wildlife. Nat Microbiol. 4(8):1337–1343.
  • Carroll J, Field D, O'Connor PM, Cotter PD, Coffey A, Hill C, Ross RP, O'Mahony J. 2010. Gene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs. Bioeng Bugs. 1(6):408–412.
  • Cascales E, Buchanan SK, Duché D, Kleanthous C, Lloubes R, Postle K, Riley M, Slatin S, Cavard D. 2007. Colicin biology. Microbiol Mol Biol Rev. 71(1):158–229.
  • Cavicchioli VQ, Camargo AC, Todorov SD, Nero LA. 2017. Novel bacteriocinogenic Enterococcus hirae and Pediococcus pentosaceus strains with antilisterial activity isolated from Brazilian artisanal cheese. J Dairy Sci. 100(4):2526–2535.
  • Chatterjee S, Chatterjee S, Lad SJ, Phansalkar MS, Rupp RH, Ganguli BN, Fehlhaber HW, Kogler H. 1992. Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization. J Antibiot. 45(6):832–838.
  • Chavan M, Rafi H, Wertz J, Goldstone C, Riley MA. 2005. Phage associated bacteriocins reveal a novel mechanism for bacteriocin diversification in Klebsiella. J Biol Chem. 284:6403–6413.
  • Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS. 2005. Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J Biol Chem. 280(13):12316–12329.
  • Cheung‐Lee WL, Parry ME, Zong C, Cartagena AJ, Darst SA, Connell ND, Russo R, Link AJ. 2020. Discovery of ubonodin, an antimicrobial lasso peptide active against members of the Burkholderia cepacia complex. Chembiochem. 21(9):1335–1340.
  • Chikindas ML, Weeks R, Drider D, Chistyakov VA, Dicks LM. 2018. Functions and emerging applications of bacteriocins. Curr Opin Biotechnol. 49:23–28.
  • Choi CH, Kwon JG, Kim SK, Myung SJ, Park KS, Sohn CI, Rhee PL, Lee KJ, Lee OY, Jung HK, et al. 2015. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial. Neurogastroenterol Motil. 27(5):705–716.
  • Chumchalová J, Smarda J. 2003. Human tumor cells are selectively inhibited by colicins. Folia Microbiol. 48(1):111–115.
  • Cintas LM, Casaus P, Holo H, Hernandez PE, Nes IF, Håvarstein LS. 1998. Enterocins L50A and L50B, two novel bacteriocins from Enterococcus faecium L50, are related to staphylococcal hemolysins. J Bacteriol. 180(8):1988–1994.
  • Cole A, Weis P, Diamond G. 1997. Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder. J Biol Chem. 272(18):1208–1213.
  • Corcoran GD, Gibbons N, Mulvihill TE. 1991. Septicaemia caused by Pediococcus pentosaceus: a new opportunistic pathogen. J Infect. 23(2):179–182.
  • Cox CL, Doroghazi JR, Mitchell DA. 2015. The genomic landscape of ribosomal peptides containing thiazole and oxazole heterocycles. BMC Genom. 16:778.
  • Cutting SM. 2011. Bacillus probiotics. Food Microbiol. 28(2):214–220.
  • Dabour N, Zihler A, Kheadr E, Lacroix C, Fliss I. 2009. In vivo study on the effectiveness of pediocin PA-1 and Pediococcus acidilactici UL5 at inhibiting Listeria monocytogenes. Int J Food Microbiol. 133(3):225–233.
  • de Kwaadsteniet M, Doeschate KT, Dicks LMT. 2009. Nisin F in the treatment of respiratory tract infections caused by Staphylococcus aureus. Lett Appl Microbiol. 48(1):65–70.
  • Dicks LMT, Endo A. 2009. Taxonomic status of lactic acid bacteria in wine and key characteristics to differentiate species. South Afr J Enol Viticult. 30(1):72–90.
  • Didari T, Solki S, Mozaffari S, Nikfar S, Abdollahi M. 2014. A systematic review of the safety of probiotics. Expert Opin Drug Saf. 13(2):227–239.
  • Dischinger J, Josten M, Szekat C, Sahl H-G, Bierbaum G. 2009. Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLOS One. 4(8):e6788.
  • dos Santos NJ, Fagundes PC, de Paiva BMA, dos Santos KR, do Carmo de FBM. 2005. Production of bacteriocins by coagulase-negative staphylococci involved in bovine mastitis. Vet Microbiol. 106(1–2):61–71.
  • Edwards IA, Elliott AG, Kavanagh AM, Zuegg J, Blaskovich MA, Cooper MA. 2016. Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of β-hairpin peptides. ACS Infect Dis. 2(6):442–450.
  • Enan G, Abdel-Shafi S, Ouda S, Negm S. 2013. Novel antibacterial activity of Lactococcus lactis subsp. lactis Z11 Isolated from Zabady. Int J Biomed Sci. 9(3):174–180.
  • Ennahar S, Sashihara T, Sonomoto K, Ishizaki A. 2000. Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol Rev. 24(1):85–106.
  • Ettayebi K, Yamani JE, Rossi-Hassani B-D. 2000. Synergistic effects of nisin and thymol on antimicrobial activities in Listeria monocytogenes and Bacillus subtilis. FEMS Microbiol Lett. 183(1):191–195.
  • Facklam RR, Elliot JA. 1995. Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding the streptococci and enterococci. Clin Microbiol Rev. 8(4):479–495.
  • FAO/WHO. 2002. Probiotics in food. Health and nutritional properties and guidelines for evaluation. FAO Food Nutr Paper. 85:1–56.
  • Fath MJ, Zhang LH, Rush J, Kolter R. 1994. Purification and characterization of colicin V from Escherichia coli culture supernatants. Biochem. 33(22):6911–6917.
  • Favaro L, Penna ALB, Todorov SD. 2015. Bacteriocinogenic LAB from cheeses – application in biopreservation? Trends Food Sci Technol. 41(1):37–48.
  • Fimland G, Johnsen L, Axelsson L, Brurberg MB, Nes IF, Eijsink VG, Nissen-Meyer J. 2000. A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum. J Bacteriol. 182(9):2643–2648.
  • Floriano B, Ruiz-Barba JL, Jiménez-Díaz R. 1998. Purification and genetic characterization of enterocin I from Enterococcus faecium 6T1a, a novel anti-listerial plasmid-encoded bacteriocin which does not belong to the pediocin family of bacteriocins. Appl Environ Microbiol. 64(12):4883–4890.
  • Foster T. 1996. Staphylococcus. In Baron S, editor. Medical microbiology. 4th edition. Chapter 12. Galveston (TX): University of Texas Medical Branch at Galveston.
  • Franz CMAP, Endo A, Abriouel H, Reenen CAV, Gálvez A, Dicks LMT. 2014. The genus Pediococcus. Ch. 21. Holzapfel WH, Wood BJB (Eds). NJ, USA: Wiley Online Library; p. 359–376.
  • Franz CMAP, van Belkum MJ, Holzapfel WH, Abriouel H, Galvez A. 2007. Diversity of enterococcal bacteriocins and their grouping in a new classification scheme. FEMS Microbiol Rev. 31(3):293–310.
  • Fredericq P. 1957. Colicins. Ann Rev Microbiol. 11:7–22.
  • Frossard CP, Steidler L, Eigenmann PA. 2007. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J Allergy Clin Immunol. 119(4):952–959.
  • Fujita K, Ichimasa S, Zendo T, Koga S, Yoneyama F, Nakayama J, Sonomoto K. 2007. Structural analysis and characterization of Lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria. Appl Environ Microbiol. 73(9):2871–2877.
  • Fuller R. 1989. Probiotics in man and animals. J Appl Microbiol. 66:365–378.
  • Gajic O, Buist G, Kojic M, Topisirovic L, Kuipers OP, Kok J. 2003. Novel mechanism of bacteriocin secretion and immunity carried out by lactococcal multidrug resistance proteins. J Biol Chem. 278(36):34291–34298.
  • Gao Y, Lu Y, Teng K-L, Chen M-L, Zheng H-J, Zhu Y-Q, Zhong J. 2011. Complete genome sequence of Lactococcus lactis subsp. lactis CV56, a probiotic strain isolated from the vaginas of healthy women. J Bacteriol. 193(11):2886–2887.
  • Ge J, Kang J, Ping W. 2019. Effect of acetic acid on bacteriocin production by gram-positive bacteria. J Microbiol Biotechnol. 29(9):1341–1348.
  • Ghavami S, Asoodeh A, Klonisch T, Halayko AJ, Kadkhoda K, Kroczak TJ, Gibson SB, Booy EP, Naderi-Manesh H, Los M. 2008. Brevinin-2R (1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J Cell Mol Med. 12(3):1005–1022.
  • Glasset B, Herbin S, Guillier L, Cadel-Six S, Vignaud ML, Grout J, Pairaud S, Michel V, Hennekinne JA, Ramarao N, et al. 2016. Bacillus cereus-induced food-borne outbreaks in France, 2007 to 2014: epidemiology and genetic characterisation. Eurosurveillance. 21(48):30413.
  • Glikman D, Sprecher H, Chernokozinsky A, Weintraub Z. 2010. Lactococcus lactis catheter-related bacteremia in an infant. Infect. 38(2):145–146.
  • Golkar Z, Bagasra O, Pace DG. 2014. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. J Infect Dev Ctries. 8(2):129–136.
  • Goroncy AK, Loo TS, Koolaard AM, Patchett ML, Norris GE. 2020. Structural characterization of the S-glycosylated bacteriocin ASM1 from Lactobacillus plantarum. Magnetochem. 6(1):16.
  • Gottler LM, Ramamoorthy A. 2009. Structure, membrane orientation, mechanism, and function of pexiganan – a highly potent antimicrobial peptide designed from magainin. Biochim Biophys Acta (BBA) – Biomembr. 1788(8):1680–1686.
  • Gould IM, Bal AM. 2013. New antibiotic agents in the pipeline and how they can help overcome microbial resistance. Virul. 4(2):185–191.
  • Guasch JF, Enfedaque J, Ferrer S, Gargallo D, Regué M. 1995. Bacteriocin 28b, a chromosomally encoded bacteriocin produced by most Serratia marcescens biotypes. Res Microbiol. 146(6):477–483.
  • Guijarro JI, González-Pastor JE, Baleux F, San Millán JL, Castilla MA, Rico M, Moreno F, Delepierre M. 1995. Chemical structure and translation inhibition studies of the antibiotic microcin C7. J Biol Chem. 270(40):23520–23532.
  • Guo Q, Goldenberg JZ, Humphrey C, Dib RE, Johnston BC. 2019. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database System Rev. 2019(4):CD004827.
  • Guz G, Colak B, Hizel K, Suyani E, Sindel S. 2006. Peritonitis due to Lactococcus lactis in a CAPD patient. Scand J Infect Dis. 38(8):698–699.
  • Güz G, Yeğin ZA, Doğan I, Hizel K, Bali M, Sindel S. 2006. Portal vein thrombosis and liver abscess due to Lactococcus lactis. Turk J Gastroenterol. 17(2):144–147.
  • Hahn-Löbmann S, Stephan A, Schulz S, Schneider T, Shaverskyi A, Tusé D, Giritch A, Gleba Y. 2019. Colicins and salmocins—new classes of plant-made non-antibiotic food antibacterials. Front Plant Sci. 10:437.
  • Han S-K, Shin M-S, Park H-E, Kim S-Y, Lee W-K. 2014. Screening of bacteriocin-producing Enterococcus faecalis strains for antagonistic activities against Clostridium perfringens. Korean J Food Sci Anim Resour. 34(5):614–621.
  • Hasper HE, Kramer NE, Smith JL, Hillman JD, Zachariah C, Kuipers OP, de Kruijff B, Breukink E. 2006. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science. 313(5793):1636–1637.
  • Heddle JG, Blance SJ, Zamble DB, Hollfelder F, Miller DA, Wentzell LM, Walsh CT, Maxwell A. 2001. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition. J Mol Biol. 307(5):1223–1234.
  • Hyronimus B, Le Marrec C, Urdaci MC. 1998. Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4. J Appl Microbiol. 85(1):42–50.
  • Ivanovics G. 1962. Bacteriocins and bacteriocin-like substances. Bacteriol Rev. 26(2 Pt 1):108–118.
  • Iwatani S, Ishibashi N, Flores FP, Zendo T, Nakayama J, Sonomoto K. 2016. LnqR, a TetR-family transcriptional regulator, positively regulates lacticin Q production in Lactococcus lactis QU 5. FEMS Microbiol Lett. 363(18):fnw200.
  • Iwatsuki M, Tomoda H, Uchida R, Gouda H, Hirono S, Ōmura S. 2006. Lariatins, antimycobacterial peptides produced by Rhodococcus sp. K01-B0171, have a lasso structure. J Am Chem Soc. 128(23):7486–7491.
  • Jack RW, Tagg JR, Ray B. 1995. Bacteriocins of gram-positive bacteria. Microbiol Rev. 59(2):171–200.
  • Jansen EF, Hirschmann DJ. 1944. Subtilin, an antibacterial substance of Bacillus subtilis. Culturing conditions and properties. Arch Biochem Biophys. 4:297–309.
  • Jenson HB, Levy SR, Duncan C, McIntosh S. 1989. Treatment of multiple brain abscesses caused by Bacillus cereus. Ped Infect Dis J. 8:795–798.
  • Jiao W, Wang S, Guan J, Shi J, Evivie SE, Yan F, Li N, Chen J, Li B, Huo G. 2020. Milk fermented with Lactococcus lactis KLDS4.0325 alleviates folate status in deficient mice. Food Funct. 11(5):4571–4581.
  • Johansen C, Gill T, Gram L. 1995. Antibacterial effect of protamine assayed by impedimetry. J Appl Bacteriol. 78(3):297–303.
  • Johnsen L, Fimland G, Nissen-Meyer J. 2005. The C-terminal domain of pediocin-like antimicrobial peptides (class IIa bacteriocins) is involved in specific recognition of the C-terminal part of cognate immunity proteins and in determining the antimicrobial spectrum. J Biol Chem. 280(10):9243–9250.
  • Joo NE, Ritchie K, Kamarajan P, Miao D, Kapila YL. 2012. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 1(3):295–305.
  • Jung D, Bodyfelt FW, Daeschel MA. 1992. Influence of fat and emulsifiers on the efficacy of nisin in inhibiting Listeria monocytogenes in fluid milk. J Dairy Sci. 75(2):387–393.
  • Kaewsrichan J, Douglas CW, Nissen-Meyer J, Fimland G, Teanpaisan R. 2004. Characterization of a bacteriocin produced by Prevotella nigrescens ATCC 25261. Lett Appl Microbiol. 39(5):451–458.
  • Kamarajan P, Hayami T, Matte B, Liu Y, Danciu T, Ramamoorthy A, Worden F, Kapila S, Kapila Y. 2015. Nisin ZP, a bacteriocin and food preservative, inhibits head and neck cancer tumorigenesis and prolongs survival. PLoS One. 10(7):e0131008.
  • Katz E, Demain AL. 1977. The peptide antibiotics of Bacillus: chemistry, biogenesis, and possible functions. Bacteriol Rev. 41(2):449–474.
  • Kaur K, Tarassova O, Dangeti RV, Azmi S, Wishart D, McMullen L, Stiles M. 2016. Characterization of a highly potent antimicrobial peptide microcin N from uropathogenic Escherichia coli. FEMS Microbiol Lett. 363(11):fnw095.
  • Kaweewan I, Hemmi H, Komaki H, Harada S, Kodani S. 2018. Isolation and structure determination of a new lasso peptide specialicin based on genome mining. Bioorg Med Chem. 26(23–24):6050–6055.
  • Kawulka KE, Sprules T, Diaper CM, Whittal RM, McKay RT, Mercier P, Zuber P, Vederas JC. 2004. Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of α-thio-α-amino acid derivatives. Biochem. 43(12):3385–3395.
  • Klaenhammer TR. 1988. Bacteriocins of lactic acid bacteria. Biochimie. 70(3):337–349.
  • Klaenhammer TR. 1993. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microb Rev. 12(1-3):39–85.
  • Kloos W, Schleifer KH. 1986. Bergey's manual of systematic bacteriology. editors. Baltimore: Williams & Wilkins.
  • Knappe TA, Linne U, Xie X, Marahiel MA. 2010. The glucagon receptor antagonist BI-32169 constitutes a new class of lasso peptides. FEBS Lett. 584(4):785–789.
  • Knerr PJ, van der Donk WA. 2012. Discovery, biosynthesis, and engineering of lantipeptides. Annu Rev Biochem. 81:479–505.
  • Kojic M, Strahinic I, Fira D, Jovcic B, Topisirovic L. 2006. Plasmid content and bacteriocin production by five strains of Lactococcus lactis isolated from semi-hard homemade cheese. Can J Microbiol. 52(11):1110–1120.
  • Krewulak KD, Vogel HJ. 2008. Structural biology of bacterial iron uptake. Biochim Biophys Acta. 1778(9):1781–1804.
  • Kruszewska D, Sahl H-G, Bierbaum G, Pag U, Hynes SO, Ljungh A. 2004. Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother. 54(3):648–653.
  • Kumar V, Singh B, van Belkum MJ, Diep DB, Chikindas ML, Ermakov AM, Tiwari SK. 2021. Halocins, natural antimicrobials of Archaea: exotic or special? Biotechnol Adv. 53:107834.
  • Ladha G, Jeevaratnam K. 2018. Probiotic potential of Pediococcus pentosaceus LJR1, a bacteriocinogenic strain isolated from rumen liquor of goat (Capra aegagrus hircus). Food Biotechnol. 32(1):60–77.
  • Lagos R, Tello M, Mercado G, García V, Monasterio O. 2009. Antibacterial and antitumorigenic properties of microcin E492, a pore-forming bacteriocin. CPB. 10(1):74–85.
  • Lagos R. 2013. Bacteriocins. In: Brenner's encyclopedia of genetics. Amsterdam (The Netherlands): Elsevier Inc; 2nd ed. p. 277–279.
  • Laureti L, Song L, Huang S, Corre C, Leblond P, Challis GL, Aigle B. 2011. Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens. Proc Natl Acad Sci USA. 108(15):6258–6263.
  • Lee HJ, Joo YJ, Park CS, Kim SH, Hwang IK, Ahn JS, Mheen TI. 1999. Purification and characterization of a bacteriocin produced by Lactococcus lactis subsp. lactis H-559 isolated from kimchi. J Biosci Bioeng. 88(2):153–159.
  • Lee JS, Chung MJ, Seo JG. 2013. In vitro evaluation of antimicrobial activity of lactic acid bacteria against Clostridium difficile. Toxicol Res. 29(2):99–106.
  • Lefevre M, Racedo SM, Ripert G, Housez B, Cazaubiel M, Maudet C, Jüsten P, Marteau P, Urdaci MC. 2015. Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study. Immun Ageing. 12(1):24.
  • Leroy F, Verluyten J, De Vuyst L. 2006. Functional meat starter cultures for improved sausage fermentation. Int J Food Microbiol. 106(3):270–285.
  • Lin Y-C, Chung K-R, Huang J-W. 2020. A synergistic effect of chitosan and lactic acid bacteria on the control of cruciferous vegetable diseases. Plant Pathol J. 36(2):157–169.
  • Ljungh A, Wadström T. 2006. Lactic acid bacteria as probiotics. Curr Issues Intest Microbiol. 7(2):73–89.
  • Lloubès R, Cascales E, Walburger A, Bouveret E, Lazdunski C, Bernadac A, Journet L. 2001. The Tol-Pal proteins of the Escherichia coli cell envelope: an energized system required for outer membrane integrity? Res Microbiol. 152(6):523–529.
  • Löfblom J, Rosenstein R, Nguyen MT, Ståhl S, Götz F. 2017. Staphylococcus carnosus: from starter culture to protein engineering platform. Appl Microbiol Biotechnol. 101(23–24):8293–8307.
  • Lohans CT, Towle KM, Miskolzie M, McKay RT, van Belkum MJ, McMullen LM, Vederas JC. 2013. Solution structures of the linear leaderless bacteriocins enterocin 7A and 7B resemble carnocyclin A, a circular antimicrobial peptide. Biochem. 52(23):3987–3994.
  • Lubelski J, Rink R, Khusainov R, Moll GN, Kuipers OP. 2008. Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cell Mol Life Sci. 65(3):455–476.
  • Lüders T, Birkemo GA, Fimland G, Nissen-Meyer J, Nes IF. 2003. Strong synergy between a eukaryotic antimicrobial peptide and bacteriocins from lactic acid bacteria. Appl Environ Microbiol. 69(3):1797–1799.
  • Luyt CE, Brechot N, Trouillet JL, Chastre J. 2014. Antibiotic stewardship in the intensive care unit. Crit Care. 18(5):480.
  • Magleby R, Bemis DA, Kim D, Carroll KC, Castanheira M, Kania SA, Jenkins SG, Westblade LF. 2019. First reported human isolation of Staphylococcus delphini. Diagn Microbiol Infect Dis. 94(3):274–276.
  • Mandal V, Sen SK, Mandal NC. 2011. Isolation and characterization of pediocin NV5 producing Pediococcus acidilactici LAB5 from vacuum-packed fermented meat product. Indian J Microbiol. 51(1):22–29.
  • Marrec CL, Hyronimus B, Bressollier P, Verneuil B, Urdaci MC. 2000. Biochemical and genetic characterization of coagulin, a new antilisterial bacteriocin in the pediocin family of bacteriocins, produced by Bacillus coagulans I4. Appl Environ Microbiol. 66(12):5213–5220.
  • Martin-Visscher LA, van Belkum MJ, Garneau-Tsodikova S, Whittal RM, Zheng J, McMullen LM, Vederas JC. 2008. Isolation and characterization of carnocyclin a, a novel circular bacteriocin produced by Carnobacterium maltaromaticum UAL307. Appl Environ Microbiol. 74(15):4756–4763.
  • Mathur H, Rea MC, Cotter PD, Hill C, Ross RP. 2015. The sactibiotic subclass of bacteriocins: an update. Curr Protein Pept Sci. 16(6):549–558.
  • Matsusaki H, Endo N, Sonomoto K, Ishizaki A. 1996. Lantibiotic nisin Z fermentative production by Lactococcus lactis IO-1: relationship between production of the lantibiotic and lactate and cell growth. Appl Microbiol Biotechnol. 45(1–2):36–40.
  • Mattick AT, Hirsch A. 1947. Further observations on an inhibitory substance (nisin) from lactic streptococci. Lancet. 2(6462):5–8.
  • McAuliffe O, Ross RP, Hill C. 2001. Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol Rev. 25(3):285–308.
  • McAuliffe O, Ryan MP, Ross RP, Hill C, Breeuwer P, Abee T. 1998. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Appl Environ Microbiol. 64(2):439–445.
  • Meindl K, Schmiederer T, Schneider K, Reicke A, Butz D, Keller S, Gühring H, Vértesy L, Wink J, Hoffmann H, et al. 2010. Labyrinthopeptins: a new class of carbacyclic lantibiotics. Angew Chem Int Ed Engl. 49(6):1151–1154.
  • Melby JO, Nard NJ, Mitchell DA. 2011. Thiazole/oxazole-modified microcins: complex natural products from ribosomal templates. Curr Opin Chem Biol. 15(3):369–378.
  • Metelev M, Arseniev A, Bushin LB, Kuznedelov K, Artamonova TO, Kondratenko R, Khodorkovskii M, Seyedsayamdost MR, Severinov K. 2017. Acinetodin and klebsidin, RNA polymerase targeting lasso peptides produced by human isolates of Acinetobacter gyllenbergii and Klebsiella pneumoniae. ACS Chem Biol. 12(3):814–824.
  • Michel-Briand Y, Baysse C. 2002. The pyocins of Pseudomonas aeruginosa. Biochimie. 84(5-6):499–510.
  • Monteiro CRAV, do Carmo MS, Melo BO, Alves MS, dos Santos CI, Monteiro SG, Bomfim MRQ, Fernandes ES, Monteiro-Neto V. 2019. In vitro antimicrobial activity and probiotic potential of Bifidobacterium and Lactobacillus against species of Clostridium. Nutr. 11(2):448.
  • Moore KS, Bevins C, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M. 1991. Antimicrobial peptides in the stomach of Xenopus laevis. J Biol Chem. 266(29):19851–19857.
  • Morton CO, Dos Santos SC, Coote P. 2007. An amphibian-derived, cationic, alpha-helical antimicrobial peptide kills yeast by caspase-independent but AIF-dependent programmed cell death. Mol Microbiol. 65(2):494–507.
  • Naclerio G, Ricca E, Sacco M, Felice MD. 1993. Antimicrobial activity of a newly identified bacteriocin of Bacillus cereus. Appl Environ Microbiol. 59(12):4313–4316.
  • Negash AW, Tsehai BA. 2020. Current applications of bacteriocin. Int J Microbiol. 2020. Article ID 4374891.
  • Nes IF, Holo H. 2000. Class II antimicrobial peptides from lactic acid bacteria. Biopol. 55(1):50–61.
  • Nissen-Meyer J, Oppegård C, Rogne P, Haugen HS, Kristiansen PE. 2011. The two-peptide (Class-IIb) bacteriocins: Genetics, biosynthesis, structure, and mode of action. In: Drider D, Rebuffat S. (Eds) Prokaryotic antimicrobial peptides. New York, NY, USA: Springer.
  • Nista EC, Candelli M, Cremonini F, Cazzato IA, Zocco MA, Franceschi F, Cammarota G, Gasbarrini G, Gasbarrini A. 2004. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther. 20(10):1181–1188.
  • Noll KS, Sinko PJ, Chikindas ML. 2011. Elucidation of the molecular mechanisms of action of the natural antimicrobial peptide subtilosin against the bacterial vaginosis-associated pathogen Gardnerella vaginalis. Probiotics Antimicrob Proteins. 3(1):41–47.
  • Norris GE, Patchett ML. 2016. The glycocins: in a class of their own. Curr Opin Struct Biol. 40:112–119.
  • Novotny JF, Perry JJ. 1992. Characterization of bacteriocins from two strains of Bacillus thermoleovorans, a thermophilic hydrocarbon-utilizing species. Appl Environ Microbiol. 58(8):2393–2396.
  • Nyangale EP, Farmer S, Keller D, Chernoff D, Gibson GR. 2014. Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086. Anaerobe. 30:75–81.
  • O’Sullivan JN, O’Connor PM, Rea MC, O’Sullivan O, Walsh CJ, Healy B, Mathur H, Field D, Hill C, Ross RP, et al. 2020. Nisin J, a novel natural nisin variant, is produced by Staphylococcus capitis sourced from the human skin microbiota. J Bacteriol. 202(3):e00639–19.
  • O'Connor PM, O'Shea EF, Guinane CM, O'Sullivan O, Cotter PD, Ross RP, Hill C. 2015. Nisin H is a new nisin variant produced by the gut-derived strain Streptococcus hyointestinalis DPC6484. Appl Environ Microbiol. 81(12):3953–3960.
  • Okazaki H, Kishi T, Beppu T, Arima K. 1975. Letter: a new antibiotic, baciphelacin. J Antibiot. 28(9):717–719.
  • Oliveira LC, Saraiva TD, Silva WM, Pereira UP, Campos BC, Benevides LJ, Rocha FS, Figueiredo HC, Azevedo V, Soares SC. 2017. Analyses of the probiotic property and stress resistance-related genes of Lactococcus lactis subsp. lactis NCDO 2118 through comparative genomics and in vitro assays. PLOS One. 12(4):e0175116.
  • Orla-Jensen S. 1919. The lactic acid bacteria. Copenhagen: Host & Sons. Denmark.
  • Oudega B, de Graaf FK. 1976. Enzymatic properties of cloacin DF13 and kinetics of ribosome inactivation. Biochim Biophys Acta. 425(3):296–304.
  • Ozawa K, Yabu-Uchi K, Yamanaka K, Yamashita Y, Ueba K, Miwatani T. 1979. Antagonistic effects of Bacillus natto and Streptococcus faecalis on growth of Candida albicans. Microbiol Immunol. 23:12–19.
  • Paik HD, Bae SS, Park SH, Pan JP. 1997. Identification and partial characterization of tochicin, a bacteriocin produced by Bacillus thuringiensis subsp. Tochigiensis. J Ind Microbiol Biotechnol. 19(4):294–298.
  • Paiva AD, de Oliveira MD, de Paula SO, Baracat-Pereira MC, Breukink E, Mantovani HC. 2012. Toxicity of bovicin HC5 against mammalian cell lines and the role of cholesterol in bacteriocin activity. Microbiology. 158(Pt 11):2851–2858.
  • Palmer JD, Piattelli E, McCormick BA, Silby MW, Brigham CJ, Bucci V. 2018. Engineered probiotic for the inhibition of Salmonella via tetrathionate-induced production of microcin H47. ACS Infect Dis. 4(1):39–45.
  • Perin LM, Todorov SD, Nero LA. 2016. Investigation of genes involved in nisin production in Enterococcus spp. strains isolated from raw goat milk. Antonie Van Leeuwenhoek. 109(9):1271–1280.
  • Pessione E. 2012. Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows. Front Cell Inf Microbiol. 22(2):86.
  • Piddock LJ. 2012. The crisis of no new antibiotics—what is the way forward? Lancet Inf Dis. 12(3):249–253.
  • Pilone GJ, Kunkee RE, Webb AD. 1966. Chemical characterization of wines fermented with various malo-lactic bacteria. J Appl Microbiol. 14(4):608–615.
  • Piper C, Casey PG, Hill C, Cotter PD, Ross RP. 2012. The lantibiotic lacticin 3147 prevents systemic spread of Staphylococcus aureus in a murine infection model. Int J Microbiol. 2012:806230.
  • Piper C, Draper LA, Cotter PD, Ross RP, Hill CA. 2009. Comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J Antimicrob Chemother. 64(3):546–551.
  • Piper C, Hill C, Cotter PD, Ross RP. 2011. Bioengineering of a Nisin A producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z. Microb Biotechnol. 4(3):375–382.
  • Pons AM, Delalande F, Duarte M, Benoit S, Lanneluc I, Sablé S, Dorsselaer AV, Cottenceau G. 2004. Genetic analysis and complete primary structure of microcin L. Antimicrob Agents Chemother. 48(2):505–513.
  • Potterat O, Stephan H, Metzger JW, Gnau V, Zähner H, Jung G. 1994. Aborycin – a tricyclic 21‐peptide antibiotic isolated from Streptomyces griseoflavus. Liebigs Ann Chem. 1994(7):741–743.
  • Prangishvili D, Holz I, Stieger E, Nickell S, Kristjansson JK, Zillig W. 2000. Sulfolobicins, specific proteinaceous toxins produced by strains of the extremely thermophilic archaeal genus Sulfolobus. J Bacteriol. 182(10):2985–2988.
  • Punj V, Bhattacharyya S, Saint-Dic D, Vasu CaC, Graves J, Yamada T, Constantinou AI, Christov K, White B, Li G, et al. 2004. Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene. 23(13):2367–2378.
  • Quadri LEN, Sailer M, Roy KL, Vederas JC, Stiles ME. 1994. Chemical and genetic characterization of bacteriocins produced by Carnobacterium piscicola LV17B. J Biol Chem. 269(16):12204–12211.
  • Rakin A, Boolgakowa E, Heesemann J. 1996. Structural and functional organization of the Yersinia pestis bacteriocin pesticin gene cluster. Microbiol. 142(12):3415–3424.
  • Ray SK, Johnson MC, Ray B. 1989. Bacteriocin plasmids of Pediococcus acidilactici. J Ind Microbiol Biotechnol. 4(3):163–171.
  • Riley MA, Wertz JE. 2002. Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol. 56(1):117–137.
  • Rodriguez-Valera F, Juez G, Kushner DJ. 1982. Halocins: salt-dependent bacteriocins produced by extremely halophilic rods. Can J Microbiol. 28(1):151–154.
  • Rosengren KJ, Clark RJ, Daly NL, Göransson U, Jones A, Craik DJ. 2003. Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone. J Am Chem Soc. 125(41):12464–12474.
  • Ruíz FO, Gerbaldo G, García MJ, Giordano W, Pascual L, Barberis IL. 2012. Synergistic effect between two bacteriocin-like inhibitory substances produced by lactobacilli strains with inhibitory activity for Streptococcus agalactiae. Curr Microbiol. 64(4):349–356.
  • Ryan MP, Meaney WJ, Ross RP, Hill C. 1998. Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens. Appl Environ Microbiol. 64(6):2287–2290.
  • Ryan MP, Rea MC, Hill C, Ross RP. 1996. An application in cheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl Environ Microbiol. 62(2):612–619.
  • Sahl HG, Bierbaum G. 1998. Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. Annu Rev Microbiol. 52:41–79.
  • Salman M, Bukhari SA, Shahid M, Sahar T, Naheed S. 2018. Strain improvement of newly isolated Lactobacillus acidophilus MS1 for enhanced bacteriocin production. Turk J Biochem. 43(3):323–332.
  • Salomón RA, Farías RN. 1992. Microcin 25, a novel antimicrobial peptide produced by Escherichia coli. J Bacteriol. 174(22):7428–7435.
  • Sand SL, Oppegård C, Ohara S, Iijima T, Naderi S, Blomhoff HK, Nissen-Meyer J, Sand O. 2010. Plantaricin A, a peptide pheromone produced by Lactobacillus plantarum, permeabilizes the cell membrane of both normal and cancerous lymphocytes and neuronal cells. Peptides. 31(7):1237–1244.
  • Santagati M, Scillato M, Patane F, Aiello C, Stefani S. 2012. Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol Med Microbiol. 65(1):23–31.
  • Sarma P, Mohanty S. 1998. Pediococcus acidilactici pneumonitis and bacteremia in a pregnant woman. J Clin Microbiol. 36(8):2392–2393.
  • Sassone-Corsi M, Nuccio SP, Liu H, Hernandez D, Vu CT, Takahashi AA, Edwards RA, Raffatellu M. 2016. Microcins mediate competition among Enterobacteriaceae in the inflamed gut. Nature. 540(7632):280–283.
  • Shafia F. 1966. Thermocins of B. stearothermophilus. J Bacteriol. 92(2):524–525.
  • Shand RF, Leyva KJ. 2007. Peptide and protein antibiotics from the domain archaea: halocins and sulfolobicins. In Riley MA, Chavan MA (Eds). Bacteriocins: ecology and evolution. Berlin: Springer; p. 93–109.
  • Sharma S, Waterfield N, Bowen D, Rocheleau T, Holland L, James R, Ffrench-Constant R. 2002. The lumicins: novel bacteriocins from Photorhabdus luminescens with similarity to the uropathogenic-specific protein (USP) from uropathogenic Escherichia coli. FEMS Microbiol Lett. 214(2):241–249.
  • Shi J, Ross CR, Chengappa MM, Sylte MJ, McVey DS, Blecha F. 1996. Antibacterial activity of a synthetic peptide (PR-26) derived from PR-39, a prolinearginine-rich neutrophil antimicrobial peptide. Antimicrob Agents Chemother. 40(1):115–121.
  • Shin HS, Baek DH, Lee SH. 2018. Inhibitory effect of Lactococcus lactis on the bioactivity of periodontopathogens. J Gen Appl Microbiol. 64(2):55–61.
  • Siddegowda GS, Bhaskar N, Gopal S. 2017. Fermentative properties of proteolytic pediococcus strains isolated from salt fermented fish hydrolysate prepared using freshwater fish rohu (Labeo rohita). J Aqua Food Prod Technol. 26(3):341–355.
  • Silkin L, Hamza S, Kaufman S, Cobb SL, Vederas JC. 2008. Spermicidal bacteriocins: lacticin 3147 and subtilosin A. Bioorg Med Chem Lett. 18(10):3103–3106.
  • Simmonds RS, Pearson L, Kennedy RC, Tagg JR. 1996. Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881. Appl Environ Microbiol. 62(12):4536–4541.
  • Sire JM, Donnio PY, Mesnard R, Pouedras P, Avril JL. 1992. Septicemia and hepatic abscess caused by Pediococcus acidilactici. Eur J Clin Microbiol Infect Dis. 11(7):623–625.
  • Skariyachan S, Govindarajan S. 2019. Biopreservation potential of antimicrobial protein producing Pediococcus spp. towards selected food samples in comparison with chemical preservatives. Int J Food Microbiol. 291:189–196.
  • Sliman R, Rehm S, Shlaes DM. 1987. Serious infections caused by Bacillus sp. Med Baltimore. 66:218–223.
  • Snauwaert I, Stragier P, De Vuyst L, Vandamme P. 2015. Comparative genome analysis of Pediococcus damnosus LMG 28219, a strain well-adapted to the beer environment. BMC Gen. 16(1):267.
  • Soballe PW, Maloy WL, Myrga ML, Jacob LS, Herlyn M. 1995. Experimental local therapy of human melanoma with lytic magainin peptides. Int J Cancer. 60(2):280–284.
  • Song AA-L, In LLA, Lim SHE, Rahim RA. 2017. A review on Lactococcus lactis: from food to factory. Microb Cell Fact. 16(1):55.
  • Stackebrandt E, Teuber M. 1988. Molecular taxonomy and phylogenetic position of lactic acid bacteria. Biochimie. 70(3):317–324.
  • Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 289(5483):1352–1355.
  • Stepper J, Shastri S, Loo TS, Preston JC, Novak P, Man P, Moore CH, Havlíček V, Patchett ML, Norris GE. 2011. Cysteine S-glycosylation, a new post-translational modification found in glycopeptide bacteriocins. FEBS Lett. 585(4):645–650.
  • Stull JW, Slavić D, Rousseau J, Weese J. 2014. Staphylococcus delphini and methicillin-resistant S. pseudintermedius in Horses, Canada. Emerg Infect Dis. 20(3):485–487.
  • Sutyak KE, Anderson RA, Dover SE, Feathergill KA, Aroutcheva AA, Faro S, Chikindas ML. 2008. Spermicidal activity of the safe natural antimicrobial peptide subtilosin. Inf Dis Obst Gynecol. 2008:540758.
  • Taheur FB, Kouidhi B, Fdhila K, Elabed H, Slama RB, Mahdouani K, Bakhrouf A, Chaieb K. 2016. Anti-bacterial and anti-biofilm activity of probiotic bacteria against oral pathogens. Microb Pathog. 97:213–220.
  • Thomas LV, Clarkson MR, Delves-Broughton J. 2000. Nisin. p. 463–524. In Naidu AS (Ed.), Natural food antimicrobial systema. Boca-Raton, FL, USA: CRC Press.
  • Thouzeau C, Le Maho Y, Froget G, Sabatier L, Le Bohec C, Hoffmann JA, Bulet P. 2003. Spheniscins, avian beta-defensins in preserved stomach contents of the king penguin, Aptenodytes patagonicus. J Biol Chem. 278(51):51053–51058.
  • Tietz JI, Schwalen CJ, Patel PS, Maxson T, Blair PM, Tai H-C, Zakai UI, Mitchell DA. 2017. A new genome-mining tool redefines the lasso peptide biosynthetic landscape. Nat Chem Biol. 13(5):470–478.
  • Todorov SD, Cavicchioli VQ, Ananieva M, Bivolarski VP, Vasileva TA, Hinkov AV, Todorov DG, Shishkov S, Haertle T, Iliev IN, et al. 2020. Expression of coagulin A with low cytotoxic activity by Pediococcus pentosaceus ST65ACC isolated from raw milk cheese. J Appl Microbiol. 128(2):458–472.
  • Todorov SD, Franco BDGM, Tagg JR. 2019. Bacteriocins of Gram-positive bacteria having activity spectra extending beyond closely-related species. Benef Microbes. 10(3):315–328.
  • Tsubura S, Waki Y, Tsubura T. 2012. Probiotic effect of Bacillus subtilis tablets on periodontopathic oral bacteria. Microbiol Res. 3:e23.
  • Tuazon CU, Hill R, Sheagren JN. 1974. Microbiologic study of street heroin and injection paraphernalia. J Infect Dis. 129(3):327–329.
  • Tuazon CU. 2000. Other Bacillus species. In Principles and practice of infectious diseases, Mandell Bennett Dolin eds., New York: Churchill Livingston; p. 2220–2226.
  • Turgis M, Vu K, Jamshidian M, Maherani B, Lacroix M. 2016. Synergistic antimicrobial effect of combined bacteriocins against food pathogens and spoilage bacteria. Microbiol Res Int. 4(1):1–5.
  • Umu ÖC, Bäuerl C, Oostindjer M, Pope PB, Hernández PE, Pérez-Martínez G, Diep DB. 2016. The potential of class II bacteriocins to modify gut microbiota to improve host health. PLOS One. 11(10):e0164036.
  • Uyttendaele M, Debevere J. 1994. Protamine evaluation of the antimicrobial activity of protamine. Food Microb. 11(5):417–427.
  • Valiante V, Monteiro MC, Martín J, Altwasser R, Aouad NE, González I, Kniemeyer O, Mellado E, Palomo S, de Pedro N, et al. 2015. Hitting the caspofungin salvage pathway of human-pathogenic fungi with the novel lasso peptide humidimycin (MDN-0010). Antimicrob Agents Chemother. 59(9):5145–5153.
  • Varaldo PE, Kilpper-Balz R, Biavasco F, Satta G, Schleifer KH. 1988. Staphylococcus delphini sp. nov., a coagulase-positive species isolated from dolphins. Int J System Bacteriol. 38(4):436–439.
  • Vassiliadis G, Destoumieux-Garzón D, Lombard C, Rebuffat S, Peduzzi J. 2010. Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47. Antimicrob Agents Chemother. 54(1):288–297.
  • Vaucher RA, Teixeira ML, Brandelli A. 2010. Investigation of the cytotoxicity of antimicrobial peptide P40 on eukaryotic cells. Curr Microbiol. 60(1):1–5.
  • Ventola CL. 2015. The antibiotic resistance crisis. Part 1: causes and threats. Pharm Therap. 40(4):277–283.
  • Vidhyasagar V, Jeevaratnam J. 2013. Evaluation of Pediococcus pentosaceus strains isolated from Idly batter for probiotic properties in vitro. J Funct Foods. 5(1):235–243.
  • Villarante KI, Elegado FB, Iwatani S, Zendo T, Sonomoto K, de Guzman EE. 2011. Purification, characterization and in vitro cytotoxicity of the bacteriocin from Pediococcus acidilactici K2a2-3 against human colon adenocarcinoma (HT29) and human cervical carcinoma (HeLa) cells. World J Microbiol Biotechnol. 27(4):975–980.
  • Weber W, Fischli W, Hochuli E, Kupfer E, Weibel EK. 1991. Anantin-a peptide antagonist of the atrial natriuretic factor (ANF). I. Producing organism, fermentation, isolation and biological activity. J Antibiot. 44(2):164–171.
  • Wertz JE, Riley MA. 2004. Chimeric nature of two plasmids of Hafnia alvei encoding the bacteriocins alveicins A and B. J Bacteriol. 186(6):1598–1605.
  • Wiedemann I, Böttiger T, Bonelli RR, Wiese A, Hagge SO, Gutsmann T, Seydel U, Deegan L, Hill C, Ross P, et al. 2006. The mode of action of the lantibiotic lacticin 3147 – a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol. 61(2):285–296.
  • Wu J, Hu S, Cao L. 2007. Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob Agents Chemother. 51(9):3131–3135.
  • Wyss DF, Lahm HM, Manneberg M, Labhardt AM. 1991. Anantin-A peptide antagonist of the atrial natriuretic factor (ANF). II. Determination of the primary sequence by NMRon the basis of proton assignments. J Antibiot. 44(2):172–180.
  • Yang SC, Lin CH, Sung CT, Fang JY. 2014. Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol. 5:241.
  • Yang X, Wang Y, Huo G. 2013. Complete genome sequence of Lactococcus lactis subsp. lactis KLDS4.0325. Gen Announc. 1(6):e00962–13.
  • Zendo T, Fukao M, Ueda K, Higuchi T, Nakayama J, Sonomoto K. 2003. Identification of the lantibiotic nisin Q, a new natural nisin variant produced by Lactococcus lactis 61-14 isolated from a river in Japan. Bios Biotechnol Biochem. 67(7):1616–1619.
  • Zhang B, Li A, Zuo F, Yu R, Zeng Z, Ma H, Chen S. 2016. Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT-29 cells. Microb Cell Fact. 15(1):102.
  • Zheng J, Wittouck S, Salvetti E, Franz CMAP, Harris HMB, Mattarelli P, O'Toole PW, Pot B, Vandamme P, Walter J, et al. 2020. A taxonomic note on the genus Lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int J Syst Evol Microbiol. 70(4):2782–2858.
  • Zoumpopoulou G, Pepelassi E, Papaioannou W, Georgalaki M, Maragkoudakis PA, Tarantilis PA, Polissiou M, Tsakalidou E, Papadimitriou K. 2013. Incidence of bacteriocins produced by food-related lactic acid bacteria active towards oral pathogens. Int J Mol Sci. 14(3):4640–4654.
  • Zschüttig A, Zimmermann K, Blom J, Goesmann A, Pöhlmann C, Gunzer F. 2012. Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10. PLOS One. 7(3):e033351.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.